Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Voyageur Signs Letter of Intent with Large Multinational Pharmaceutical Company (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Quantum BioPharma Ltd C.QNTM

Alternate Symbol(s):  QNTM

Healthcare Biotechnology
Quantum BioPharma Ltd. is a Canada-based biopharmaceutical company. The Company is engaged in building a portfolio of assets and biotech solutions for the treatment of challenging neurodegenerative and metabolic disorders and alcohol misuse disorders with drug candidates in different stages of development. Through its wholly owned subsidiary, Lucid Psycheceuticals Inc. (Lucid), it is focused on the research and development of its lead compound, Lucid-MS, which is a patented new chemical entity to prevent and reverse myelin degradation, the underlying mechanism of multiple sclerosis. Its unbuzzd beverage is a proprietary formulation of vitamins and minerals to help with liver and brain function for the purposes of relieving the effects of alcohol consumption and restoring a normal lifestyle. It maintains a portfolio of strategic investments through its wholly owned subsidiary, FSD Strategic Investments Inc., which represents loans secured by residential or commercial property.


CSE:QNTM - Post by User

Quantum BioPharma Ltd
Bullboard Posts
User Avatar Image
(0)
•••
Post by AbrahamSTon Jan 31, 2019 9:43am
195 Views
Post# 29300844

HUGE IS SOARING. - 50 CLOSE TODAY

HUGE IS SOARING. - 50 CLOSE TODAY

CORRECTION FROM SOURCE: FSD Pharma Plans on Becoming the Largest Producer in the World, CEO Clip Video (new video)

FSDDF | 16 hours ago

 

Vancouver, British Columbia--(Newsfile Corp. - January 30, 2019) - Rupert Haynes, CEO of FSD Pharma, speaks about pivoting from medical marijuana to a pharmaceutical company.


If you cannot view the video above, please visit:
https://www.b-tv.com/fsd-pharma-ceo-clips-90sec/

FSD Pharma is being featured on BNN Bloomberg on Feb. 2 - Feb. 3, 2019, throughout the day and evenings.

FSD Pharma (CSE: HUGE)

fsdpharma.com

About CEO Clips:

CEO Clips is the largest library of publicly traded company CEO videos in Canada and the US. These 90 second video profiles broadcast on national TV and online via 15 top financial sites including: Thomson Reuters, Bloomberg, Yahoo! Finance and Stockhouse.com.

BTV - Business Television/CEO Clips Contact: Trina Schlingmann (604) 664-7401 x 5 trina@b-tv.com

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/42566


Read more at https://stockhouse.com/news/press-releases/2019/01/30/correction-from-source-fsd-pharma-plans-on-becoming-the-largest-producer-in-the#kxqPWbvuVWlIqE7f.99
Bullboard Posts
Dealroom for high-potential pre-IPO opportunities